PYC Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/28/2024
PYC Therapeutics Stock Forecast and Price Target
The average target price set lately by experts for PYC Therapeutics to reach by the end of the year is $0.35, which would imply a potential upside of approximately 288.89 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $0.39 and a low estimate of $0.30. You may be interested in rivals even if you aren't interested in PYC Therapeutics stock.
288.89% Upside
PYC Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last year, PYC Therapeutics's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that PYC Therapeutics's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SAN Stock Forecast | Sanofi | Outperform |
16
|
91.23€ | Buy/Sell | 102.80€ | 19.48% |
| 4568 Stock Forecast | Daiichi Sankyo Company | Buy |
4
|
¥5.01k | Buy/Sell | ¥5.24k | 15.77% |
| 4502 Stock Forecast | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.09k | Buy/Sell | ¥4.74k | 11.27% |
| MRNA Stock Forecast | Moderna | Outperform |
16
|
$107.97 | Buy/Sell | $135.42 | 15.22% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$208.90 | Buy/Sell | $299.62 | 38.10% |
PYC Therapeutics Revenue Forecast for 2023 - 2025 - 2030
In the last three years, PYC Therapeutics's Revenue has grown by 558.75%, rising from $2.40M to $15.81M. According to 0 analysts, PYC Therapeutics's Revenue will fall by 33.74% in the next year, reaching $10.48M. Professionals believe that By 2030, PYC Therapeutics's Revenue will fall to $11.44M – a 27.64% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$143.31 | Buy/Sell | $245.24 | 50.02% |
| BMRN Stock Forecast | BioMarin Pharmaceutical | Outperform |
10
|
$80.91 | Buy/Sell | $111.56 | 35.95% |
| SRPT Stock Forecast | Sarepta Therapeutics | Outperform |
6
|
$128.77 | Buy/Sell | $158.66 | 28.52% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$41.59 | Buy/Sell | $55.60 | 44.75% |
| DYN Stock Forecast | Dyne Therapeutics | Buy |
5
|
$24.73 | Buy/Sell | $28.13 | 45.57% |
| 4516 Stock Forecast | Nippon Shinyaku | Outperform |
18
|
¥4.34k | Buy/Sell | ¥8.34k | 49.94% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DCPH Stock Forecast | Deciphera Pharmaceuticals | Outperform |
6
|
$14.65 | Buy/Sell | $23.40 | 67.24% |
| WVE Stock Forecast | Wave Life Sciences | Outperform |
6
|
$4.66 | Buy/Sell | $9.21 | 189.70% |
| STOK Stock Forecast | Stoke Therapeutics | Buy |
4
|
$12.41 | Buy/Sell | $19.33 | 69.22% |
PYC Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
PYC Therapeutics's EBITDA has grown In the last three years, rising from $-6.92M to $-22.80M – a growth of 229.48%. For the following year, the 0 analysts predict that PYC Therapeutics's EBITDA will drop by 22.77%, reaching $-17.61M. In 2030, the professionals' prediction is that PYC's EBITDA will decrease by 18.29%, reaching $-18.63M.
PYC Therapeutics EBIT Forecast for 2023 - 2025 - 2030
PYC Therapeutics's EBIT has seen impressive growth In the last three years, rising from $-7.31M to $-23.43M – a growth of 220.52%. In the following year, the 0 analysts surveyed believe that PYC Therapeutics's EBIT will decrease by 22.92%, reaching $-18.06M. According to professionals, by 2030, PYC Therapeutics's EBIT will have decreased by 18.47%, falling down to $-19.10M.
PYC Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, PYC Therapeutics's EPS has grown by 100.00%, rising from $-0.01 to $0.00. For next year, analysts predict EPS of $0.00, which would mean an increase of 100.00%. Over the next six years, experts predict that PYC Therapeutics's EPS will grow at a rate of 100.00%.
.jpg)